Aurobindo Pharma is recalling another lot of Valsartan tablets due to possible cancer-causing chemicals.
The 160mg pills with an expiration date of March 31,202 are being recalled.
This medicine is used to treat high blood pressure and heart failure.
Patients are encouraged to continue taking the medicine until their doctor prescribes an alternative.
This one of several recalls linked to Valsartan.
In November, Teva Pharmaceuticals issued a voluntary recall of its amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets, both used to treat high blood pressure, according to the FDA.
These drugs are being recalled due to the detection of a probable human carcinogen known as NDEA, which has been found in Valsartan API, the FDA said.